Left-Main Disease: When is PCI the Preferred Strategy?

Por Dr. Rafael Cavalcante.

Rafaael Cavalcante

More articles by this author

Venus P-Valve: The valve and initial clinical worldwide experience

Por Dr. Alejandro Peirone.

FFR EM LESÕES SEQUENCIAIS E DOENÇA DIFUSA

Por Dr. Silvio Gioppato.  

Erros mais comuns na realização do FFR: como identificá-los e preveni-los

Por Dr. Fernando Mendes Sant’Anna.  

Análise Crítica do Estudo Leaders É o melhor stent que temos?

Por Dr. Esmeralci Ferreira.  

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...